Photon Capital (509084)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades near book value: P/B 1.02 versus stated book value of ₹69.54, offering possible downside support if the assets are real.
• Tiny ₹11 Cr market cap means even modest asset monetisation or a meaningful new business move could move the stock sharply.
• Piotroski F-score of 5/9 is neither distressed nor strong, leaving room for improvement if operations stabilise.
• Reported profit growth of 159.46% indicates a swing from earlier weakness, though the base is negligible.

Concerns

• Negative ROE of -5.96% and ROCE of -5.55% show the business is destroying shareholder value, not compounding it.
• Sales fell 16.67%, and the latest quarter shows ₹0 Cr revenue and ₹0 Cr net profit, revealing no active operating engine.
• P/E of 454.25 and PEG of 2.85 are unreliable with negligible earnings; current price is also below the stated 52-week low of ₹90.
• No dividend, no promoter holding data, and debt/equity not available make governance and balance-sheet risk hard to assess.

AI Analysis

At first glance, this is not my kind of business. Buffett and Graham teach us to buy a wonderful business at a fair price, or a fair business at a wonderful price, but Photon Capital gives me neither with confidence. The company has a market cap of ₹11 Cr and trades at ₹70.75, barely above its book value of ₹69.54. A P/B of 1.02 looks interesting, but book value only matters if the assets can earn a reasonable return. Here ROE is -5.96% and ROCE is -5.55%, so capital is being destroyed, not compounded. Sales fell 16.67%, and the latest quarter shows revenue of ₹0 Cr and net profit of ₹0 Cr. That makes the headline P/E of 454.25 and the profit growth of 159.46% almost statistical illusions; a small swing from a tiny base can create huge percentage changes. The Piotroski F-score of 5/9 is mediocre, and the 0% dividend gives me no income protection. The current price is below the stated 52-week low range, which tells me investors are not treating this as a stable going concern. Without promoter holding data or debt/equity data, I cannot gauge governance or leverage. As a Graham-style investor, I would demand a deep margin of safety. At nearly 1x book, I am paying full price for asset value that may not be realisable. If the business cannot turn ROE positive, book value could be impaired further. This is not a quality compounder; it is an asset-backed special situation. I would only consider it as a small speculative play if management can redeploy or unlock assets and if the underlying book value is verified. Otherwise, patience is better.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer